IRF1基因敲除A549细胞

IRF1基因敲除A549细胞
货号:

EDJ-KQ21084

物种:

细胞名称:

A-549

基因名称:

IRF1

基因ID:

3659

规格:

1×10⁶cells

IRF1基因敲除细胞A549是由艾迪基因优化的CRISPR/Cas9编辑而成,采用Sanger测序法验证敲除,保证单克隆,活性良好。
货号 EDJ-KQ21084
产品名称 IRF1 Knockout A549 Cell Line
细胞 A549
Cellosaurus ID CVCL_0023
细胞别名 A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549
基因 IRF1
基因ID
基因别名 IMD117|IRF-1|MAR
摘要
The protein encoded by this gene is a transcriptional regulator and tumor suppressor, serving as an activator of genes involved in both innate and acquired immune responses. The encoded protein activates the transcription of genes involved in the body's response to viruses and bacteria, playing a role in cell proliferation, apoptosis, the immune response, and DNA damage response. This protein represses the transcription of several other genes. As a tumor suppressor, it both suppresses tumor cell growth and stimulates an immune response against tumor cells. Defects in this gene have been associated with gastric cancer, myelogenous leukemia, and lung cancer. [provided by RefSeq, Aug 2017]
癌症类型 Non-Small Cell Lung Carcinoma
细胞形态 Adherent
传代比率 1/5-1/4 ,2days
完全培养基 F-12K + 10% FBS
冻存培养基 95% 完全培养基 + 5% DMSO
* 仅供科研使用,不适用于人体或动物,包括临床、治疗或诊断用途。
Loci送检细胞STR信息
送检细胞名: A-549
细胞库细胞STR信息
细胞库细胞名: A-549
Allele1Allele2Allele1 Allele2
AmelogeninX YXY
CSF1PO10121012
D2S13382424
D3S13581616
D5S8181111
D7S820811811
D8S117913141314
D13S3171111
D16S53911121112
D18S5114171417
D19S4331313
D21S112929
FGA2323
Penta D99
Penta E711711
TH0189.389.3
TPOX811811
vWA1414
D6S10431113
D12S3911818
D2S44110131013
* 该细胞系与收录于ATCC, DSMZ, JCRB 和 RIKEN数据库的细胞系STR数据匹配。
结论:该细胞 STR 鉴定正确。
* 研究用途免责声明:本内容基于公开的研究数据、生物信息学资源及计算分析生成,仅供研究参考。

相关研究文献

IF=16.6
Molecular cell
Interferon-γ (IFN-γ)-mediated adaptive resistance is one major barrier to improving immunotherapy in solid tumors. However, the mechanisms are not completely understood. Here, we report that IFN-γ promotes nuclear translocation and phase separation of YAP after anti-PD-1 therapy in tumor cells. Hydrophobic interactions of the YAP coiled-coil domain mediate droplet initiation, and weak interactions of the intrinsically disordered region in the C terminus promote droplet formation. YAP partitions with the transcription factor TEAD4, the histone acetyltransferase EP300, and Mediator1 and forms transcriptional hubs for maximizing target gene transcriptions, independent of the canonical STAT1-IRF1 transcription program. Disruption of YAP phase separation reduced tumor growth, enhanced immune response, and sensitized tumor cells to anti-PD-1 therapy. YAP activity is negatively correlated with patient outcome. Our study indicates that YAP mediates the IFN-γ pro-tumor effect through its nuclear phase separation and suggests that YAP can be used as a predictive biomarker and target of anti-PD-1 combination therapy.
IF=5.2
Cells
Host cell-intrinsic antiviral responses are largely mediated by pattern-recognition receptor (PRR) signaling and the interferon (IFN) system. The IFN regulatory factor (IRF) family of transcription factors takes up a central role in transcriptional regulation of antiviral innate immunity. IRF3 and IRF7 are known to be key players downstream of PRRs mediating the induction of type I and III IFNs. IFN signaling then requires IRF9 for the expression of the full array of interferon stimulated genes (ISGs) ultimately defining the antiviral state of the cell. Other members of the IRF family clearly play a role in mediating or modulating IFN responses, such as IRF1, IRF2 or IRF5, however their relative contribution to mounting a functional antiviral response is much less understood. In this study, we systematically and comparatively assessed the impact of six members of the IRF family on antiviral signaling in alveolar epithelial cells. We generated functional knockouts of IRF1, -2, -3, -5, -7, and -9 in A549 cells, and measured their impact on the expression of IFNs and further cytokines, ISGs and other IRFs, as well as on viral replication. Our results confirmed the vital importance of IRF3 and IRF9 in establishing an antiviral state, whereas IRF1, 5 and 7 were largely dispensable. The previously described inhibitory activity of IRF2 could not be observed in our experimental system.
IF=4.9
International journal of molecular sciences
Interferon-γ (IFNγ), a key inflammatory cytokine that orchestrates immune responses, also emerges as a regulator of cellular metabolism; however, in alveolar epithelial cells its impact on amino acid homeostasis remains poorly defined. Here, we investigated the effects of IFNγ on intracellular amino acid content and transmembrane transport in human alveolar epithelial A549 cells, focusing on the contribution of the JAK/STAT/IRF1 signaling axis. To this end, A549 WT and IRF1 knockout (IRF1 KO) cells were used to investigate IRF1 contribution, and baricitinib to evaluate the role of the JAK/STAT pathway. HPLC analysis reveals that in WT, but not in IRF1 KO cells, IFNγ markedly increases the intracellular concentration of many amino acids, including glutamine, glutamate, and several neutral and cationic amino acids, without affecting the cell volume, thus indicating true metabolic accumulation. The measurement of the transmembrane uptake of specific radiolabeled amino acids demonstrates a concomitant increase in transport Systems ASC, A, L, and y activity; an upregulation of the related transporters ASCT2, SNAT2, LAT1, and CAT1 has also been observed by means of qPCR analysis. Moreover, conditioned medium from SARS-CoV-2 spike-activated macrophages recapitulates IFNγ-driven amino acid remodeling in a JAK/STAT/IRF1-dependent manner. Overall, our findings identify IFNγ as a potent regulator of intracellular amino acid availability in alveolar epithelial cells through the modulation of the activity of membrane transporters. The observed IFNγ-reprogramming is IRF1 dependent, ascribing a crucial role to this transcription factor in linking inflammation and amino acid metabolism.
该敲除模型可用于: - 研究IRF1在干扰素-γ介导的肿瘤免疫逃逸和抗PD-1免疫治疗抵抗中的作用。 - 研究肺泡上皮细胞中IRF1依赖性抗病毒信号通路。 - 阐明STAT/IRF1轴在调节氨基酸转运和细胞代谢中的作用。 - 先天免疫反应中IRF家族内IRF1的功能表征。 - 筛选靶向IRF1驱动的免疫抵抗或代谢重编程的治疗药物。

配套产品

相关产品

A-549(人非小细胞肺癌)A-549(人非小细胞肺癌)

相关服务

基因敲除细胞基因敲除细胞
联系我们
*
*
*
来源:
service online

  • 留言
  • You can send email to contact us.
    邮箱
  • You can send email to contact us.
    电话
    联系电话
    中国总部
    18102225074(微信同号)

  •  回到顶部